Morgan Stanley Comments on Walgreen

Morgan Stanley provided color on Walgreen WAG in a research report published today. The investment firm has an Underweight rating and $29 price target for Walgreen. In the report, Morgan Stanley said, "Walgreen shares could come under pressure in reaction to disappointing pharmacy margins in 1Q and news that Express Scripts rebuffed a Walgreens offer to resolve their dispute. We see significant disruption and script losses for Walgreens starting Jan 1." Shares of Walgreens closed today at $33.37, down 0.39% from Tuesday's market close.